首页> 外文期刊>BMC Medical Genomics >Meta-Qtest: meta-analysis of quadratic test for rare variants
【24h】

Meta-Qtest: meta-analysis of quadratic test for rare variants

机译:Meta-Qtest:针对稀有变异的二次检验进行荟萃分析

获取原文
       

摘要

In genome-wide association studies (GWASs), meta-analysis has been widely used to improve statistical power by combining the results of different studies. Meta-analysis can detect phenotype associated variants that are failed to be detected in single studies. Especially, in biomedical sciences, meta-analysis is often necessary not only for improving statistical power, but also for reducing unavoidable limitation in data collection. As next-generation sequencing (NGS) technology has been developed, meta-analysis of rare variants is proceeding briskly along with meta-analysis of common variants in GWASs. However, meta-analysis on a single variant that is commonly used in common variant association test is improper for rare variants. A sparse signal of rare variant undermines the association signal and its large number causes multiple testing problem. To over-come these problems, we propose a meta-analysis method at the gene-level rather than variant level. Among many methods that have been developed, we used the unified quadratic tests (Q-tests); Q-test is more powerful than or as powerful as other tests such as Sequence Kernel Association Tests (SKAT). Since there are three different versions of Q-test (QTest1, QTest2, QTest3), each assumes different relationships among multiple rare variants, we extended them into meta-study accordingly. For meta-analysis, we consider two types of approaches, the one is to combine regression coefficients and the other is to combine test statistics from each single study. We extend the Q-test for meta-analysis, proposing Meta Quadratic Test (Meta-Qtest). Meta Q-test avoids the limitations of MetaSKAT. It does not only consider genetic heterogeneity among studies as MetaSKAT but also reflects diverse real situations; since we extend three different Q-tests into meta-analysis respectively, flexible Meta Q-test suggests way to deal with gene-level rare variant meta-analysis efficiently From the results of real data analysis of blood pressure trait, our meta-analysis could successfully discovered genes, KCNA5 and CABIN1 that are already well known for relevance with hypertension disease and they are not detected in MetaSKAT. As exemplified by an application to T2D Genes projects data set, Meta-Qtest more effectively identified genes associated with hypertension disease than MetaSKAT did.
机译:在全基因组关联研究(GWAS)中,荟萃分析已被广泛用于通过结合不同研究的结果来提高统计能力。荟萃分析可以检测在单项研究中未能检测到的表型相关变异。特别地,在生物医学科学中,通常不仅需要进行荟萃分析,以提高统计能力,而且还需要减少不可避免的数据收集限制。随着下一代测序(NGS)技术的发展,稀有变体的荟萃分析与GWAS中常见变体的荟萃分析一起蓬勃发展。但是,对于常见变体关联测试中常用的单个变体的荟萃分析不适用于稀有变体。稀有变体的稀疏信号会破坏关联信号,并且其数量庞大会导致多重测试问题。为了克服这些问题,我们提出了在基因水平而不是变异水平的荟萃分析方法。在已经开发的许多方法中,我们使用了统一的二次检验(Q检验)。 Q-test比其他测试(例如,序列内核关联测试(SKAT))更强大或更强大。由于存在三种不同版本的Q-test(QTest1,QTest2,QTest3),每个版本都假设多个稀有变量之间具有不同的关系,因此我们将其扩展为元研究。对于荟萃分析,我们考虑两种类型的方法,一种是组合回归系数,另一种是组合每个研究的检验统计量。我们扩展了用于荟萃分析的Q检验,提出了Meta二次检验(Meta-Qtest)。 Meta Q-test避免了MetaSKAT的局限性。它不仅将研究之间的遗传异质性视为MetaSKAT,而且反映了各种实际情况。由于我们分别将三个不同的Q检验扩展到荟萃分析中,因此灵活的Meta Q检验提出了有效处理基因水平稀有变异荟萃分析的方法。根据对血压性状的真实数据分析结果,我们的荟萃分析可以成功发现了与高血压疾病相关的已知基因KCNA5和CABIN1,但未在MetaSKAT中检测到。正如T2D基因计划数据集的应用所举例说明的那样,与MetaSKAT相比,Meta-Qtest更有效地鉴定了与高血压疾病相关的基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号